advertisement
Cui X 26
Showing records 1 to 25 | Display all abstracts from Cui X98430 Renormalization of metabolic coupling treats age-related degenerative disorders: an oxidative RPE niche fuels the more glycolytic photoreceptors
Nolan ND
Eye 2022; 36: 278-283
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Cui X
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Wu WH
Molecular Therapy 2022; 30: 1407-1420
98430 Renormalization of metabolic coupling treats age-related degenerative disorders: an oxidative RPE niche fuels the more glycolytic photoreceptors
Caruso SM; Caruso SM
Eye 2022; 36: 278-283
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Kim HJ
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Tsai YT
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Cheng CH
Human Molecular Genetics 2022; 31: 2438-2451
98430 Renormalization of metabolic coupling treats age-related degenerative disorders: an oxidative RPE niche fuels the more glycolytic photoreceptors
Cui X
Eye 2022; 36: 278-283
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Huang IW; Huang IW
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Jenny LA
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Cheng CH
Molecular Therapy 2022; 30: 1407-1420
98430 Renormalization of metabolic coupling treats age-related degenerative disorders: an oxidative RPE niche fuels the more glycolytic photoreceptors
Tsang SH
Eye 2022; 36: 278-283
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Hsu CW
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
De Carvalho Junior JRL; Chang YJ
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Cui X; Ryu J
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Kong Y
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Quinn PMJ
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Hsu CW
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Quinn PMJ; Quinn PMJ
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Huang IW
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Caruso SM
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Huang IW
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Caruso SM; Lin CS
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Ragi SD
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Tsang SH
Molecular Therapy 2022; 30: 1407-1420
